Teva CEO eyes disruption from tech companies

The interim president and chief executive of Teva Pharmaceutical Industries (NYSE: TEVA), Yitzhak Peterburg, has said that he believes the healthcare industry is undergoing “huge disruption.”

In an interview with US broadcaster CNBC, Dr Peterburg said he thought pharmaceutical companies would face increasing competition from non-pharmaceutical companies as a result of innovations in digital health and other technologies.

Describing the pharmaceutical industry as one of the last “traditional” industries, he said it was very difficult for incumbents to “find the right time, and the right way to move.” The solution, he says, is to “do it by collaboration with startups and with small companies.”